Elsevier

Clinical Biochemistry

Volume 25, Issue 3, June 1992, Pages 167-174
Clinical Biochemistry

Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine

https://doi.org/10.1016/0009-9120(92)90250-VGet rights and content

Osteoarthritis is a major cause of disability and early retirement. Yet we lack the means to diagnose the disease in its early stages or to monitor the effects of treatment on the target tissue, the joint cartilage. Neither can we identify the disease mechanisms at the tissue or cell level. Current research focuses on the use of markers of cartilage matrix metabolism in body fluids as a means to diagnose and monitor osteoarthritis. Cartilage proteoglycan, collagen and glycoprotein fragments, as well as proteinases and their inhibitors, are being suggested for this purpose. Structural information on matrix molecule fragments released into body fluids may also help to identify the enzymes active in the destruction of the cartilage, a central issue in osteoarthritis.

References (94)

  • DoegeKJ et al.

    Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan

    J Biol Chem

    (1991)
  • BolisS et al.

    Passive loss of proteoglycan from articular cartilage explants

    Biochim Biophys Acta

    (1989)
  • SahRL-Y et al.

    Effect of compression on the loss of newly synthesized proteoglycans and proteins from cartilage explants

    Arch Biochem Biophys

    (1991)
  • SaxneT et al.

    Synovial fluid concentration of interleukin-1beta and proteoglycans are inversely related

    J Autoimmun

    (1988)
  • CooksleyS et al.

    Immunoassays for the detection of human collagenase; stromelysin; tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes

    Matrix

    (1990)
  • FosangAJ et al.

    An ELISA plate based assay for hyaluronan using biotinylated proteoglycan-G1 domain (HA-binding region)

    Matrix

    (1990)
  • ParóczaiC et al.

    Estimation of serum anticollagen and the antibodies against chondrocyte membrane fraction: their clinical diagnostic significance in osteoarthritis

    Clin Biochem

    (1988)
  • DohertyM et al.

    Influence of primary generalised osteoarthritis on development of secondary osteoarthritis

    Lancet

    (1983)
  • SandyJD et al.

    Analysis of the catabolism of aggrecan in cartilage explants by quantitation of peptides from the three globular domains

    J Biol Chem

    (1991)
  • KramerJS et al.

    Social and economic impacts of four musculoskeletal conditions

    Arthritis Rheum

    (1983)
  • AltmanR et al.

    Development of criteria for the classification and reporting of osteoarthritis

    Arthritis Rheum

    (1986)
  • AltmanRD et al.

    Radiographic assessment of progression in osteoarthritis

    Arthritis Rheum

    (1987)
  • McAlindonT et al.

    Osteoarthritis: definitions and criteria

    Ann Rheum Dis

    (1989)
  • LohmanderLS

    Cartilage markers in joint fluid in human osteoarthritis

  • LohmanderLS

    Osteoarthritis: man, models and molecular markers

  • LohmanderLS

    Markers of cartilage matrix metabolism in arthrosis

    Acta Orthop Scand

    (1991)
  • MaroudasA

    Glycosaminoglycan turnover in articular cartilage

    Philos Trans R Soc London [Biol]

    (1975)
  • HeinegrdD et al.

    Structure and biology of cartilage and bone matrix non-collagenous macromolecules

    FASEB J

    (1989)
  • RatcliffeA et al.

    Articular cartilage cultured with interleukin 1: increased release of link proteins, hyaluronate-binding region and other proteoglycan fragments

    Biochem J

    (1986)
  • PettipherER et al.

    Leukocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit

    Br J Pharmacol

    (1988)
  • SchalwijkJ et al.

    Experimental arthritis in C57 black/6 normal and beige (Chediak-Higashi) mice: in vivo and in vitro observations on cartilage degradation

    Ann Rheum Dis

    (1988)
  • SaklatvalaJ et al.

    Pig interleukin 1: purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation and fever

    J Exp Med

    (1985)
  • CruwysSC et al.

    Co-operation between interleukin-1 and the fibrinolytic system in the degradation of collagen by articular chondrocytes

    Br J Pharmacol

    (1990)
  • DeanDD et al.

    Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage

    J Clin Invest

    (1989)
  • DochertyAJP et al.

    The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins

    Ann Rheum Dis

    (1990)
  • MurphyG et al.

    Role of regulation of metalloproteinases in connective tissue turnover

    Biochem Soc Trans

    (1990)
  • WoessnerJF

    Matrix metalloproteinases and their inhibitors in connective tissue remodeling

    FASEB J

    (1991)
  • PontonA et al.

    Decrease expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity

    Cancer Res

    (1991)
  • FraserJRE et al.

    Uptake and degradation of hyaluronan in lymphatic tissue

    Biochem J

    (1988)
  • Page-ThomasDP et al.

    Clearance of proteoglycan from joint cavities

    Ann Rheum Dis

    (1987)
  • MorelandLW et al.

    Immunohistologic demonstration of type-II collagen in synovial fluid phagocytes of osteoarthritis and rheumatoid arthritis patients

    Arthritis Rheum

    (1989)
  • TzaicosC et al.

    Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan

    Biochem J

    (1989)
  • FraserJRE et al.

    Elimination of hyaluronic acid from the blood stream in the human

    Clin Exp Pharmacol Physiol

    (1984)
  • Engström-LaurentA et al.

    The role of liver and kidneys in the removal of circulating hyaluronan, an experimental study in the rat

    Connect Tissue Res

    (1990)
  • SmedsrödB et al.

    Circulating C-terminal propeptide of type-I procollagen is cleared mainly via the mannose receptor in liver endothelial cells

    Biochem J

    (1990)
  • MaldonadoBA et al.

    Differences in the rate of clearance of different KS-bearing molecules injected intravenously in rabbits

    Orthop Trans

    (1989)
  • EyreDR et al.

    Collagen crosslinking in human bone and articular cartilage

    Age-related changes in the content of mature hydroxypyridinium residues

    Biochem J

    (1988)
  • Cited by (57)

    • Relationship between weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: secondary analyses of a randomised trial

      2017, Osteoarthritis and Cartilage
      Citation Excerpt :

      Loss of cartilage is a cardinal feature of knee osteoarthritis (KOA)1, and disease-modifying treatment still needs to be identified.

    • Effect of a 16 weeks weight loss program on osteoarthritis biomarkers in obese patients with knee osteoarthritis: A prospective cohort study

      2014, Osteoarthritis and Cartilage
      Citation Excerpt :

      Knee osteoarthritis (KOA) is characterized by loss of articular cartilage1,2 with changes in thickness, water content and mechanical properties3, as well as changes in the subchondral bone and osteophyte formation4. Cartilage biomarkers may be used to describe the degenerative status and prospectively assess metabolic processes of the joint1,5. Among these markers, Cartilage Oligomeric Matrix Protein (COMP) concentration in blood is a possible candidate to indicate pathological turnover of cartilage at early stages of arthritis, preceding ensuing structural breakdown of cartilage visible on radiography6–8, since COMP is suggested to participate in the forming and maintenance of the cartilage matrix9,10.

    • Association of plasma and synovial fluid interferon-γ inducible protein-10 with radiographic severity in knee osteoarthritis

      2011, Clinical Biochemistry
      Citation Excerpt :

      Additionally, circulating levels of TNF-α and IL-6 were associated with radiographic knee osteoarthritis and knee cartilage loss, suggesting that low level inflammation may play a role in the pathogenesis of knee OA [32]. In addition to inflammatory mediators, breakdown of articular cartilage matrix during OA leads to the generation of constituent fragments that may serve as biochemical markers of OA [2]. Cartilage oligomeric matrix protein (COMP), a member of the thrombospondin family of glycoproteins, has been proposed as a molecular marker of cartilage degradation in OA [33].

    • Osteoarthritis: An overview of the disease and its treatment strategies

      2005, Seminars in Arthritis and Rheumatism
      Citation Excerpt :

      The pathological characteristics of OA are loss of cartilage with associated underlying bony changes consisting of sclerosis, subchondral bone collapse, bone cysts, and osteophyte formation (10). The loss of articular cartilage in OA may start as a focal lesion and progressively extend to involve specific joint compartments, thus inducing alterations in articulating surfaces (11) and leading to progressive loss of cartilage (12). Superficial fibrillation is associated with the loss of the small proteoglycans, decorin, and biglycan, which are usually closely associated with the fibrils at the articular surface (13), and the large proteoglycan aggrecan (14).

    • Articular cartilage metabolism: Biochemical markers and dynamic loading

      2020, Articular Cartilage of the Knee: Health, Disease and Therapy
    View all citing articles on Scopus
    View full text